Insider Analysis From Jones Day: What Does the 3rd Amendment to China’s Patent Law Mean to Pharmaceutical Companies?
This article was originally published in PharmAsia News
You may also be interested in...
China To Implement New Regulations For Patent Law; Companies Should Set Up Inventor Reward Policy To Prepare For Changes
SHANGHAI - China's State Council recently approved new implementation regulations for the country's Patent law, which clarifies procedural issues in line with new changes to the patent law that took effect last year
China To Implement New Regulations For Patent Law; Companies Should Set Up Inventor Reward Policy To Prepare For Changes
SHANGHAI - China's State Council recently approved new implementation regulations for the country's Patent law, which clarifies procedural issues in line with new changes to the patent law that took effect last year
China’s Bribery, Spotty Drug Distribution And IP Gaps Equals … Great Opportunities?
It is no secret that China is seen as a key growth market for the pharmaceutical industry. But as appealing as the country's skyrocketing market is to companies, many barriers to expansion, including IP concerns and a slowly improving drug distribution system - remain